关注
Viktor P. Volok
Viktor P. Volok
«RUDN University (Российский университет дружбы народов)»
在 rudn.ru 的电子邮件经过验证
标题
引用次数
引用次数
年份
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies
LI Kozlovskaya, AN Piniaeva, GM Ignatyev, IV Gordeychuk, VP Volok, ...
Emerging microbes & infections 10 (1), 1790-1806, 2021
772021
Ixodid ticks and tick-borne encephalitis virus prevalence in the South Asian part of Russia (Republic of Tuva)
I Kholodilov, O Belova, L Burenkova, Y Korotkov, L Romanova, ...
Ticks and tick-borne diseases 10 (5), 959-969, 2019
312019
Phenoxazine nucleoside derivatives with a multiple activity against RNA and DNA viruses
LI Kozlovskaya, VP Volok, AA Shtro, YV Nikolaeva, AA Chistov, ...
European Journal of Medicinal Chemistry 220, 113467, 2021
222021
Structural characterization of β‐propiolactone inactivated severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) particles
DV Bagrov, GS Glukhov, AV Moiseenko, MG Karlova, DS Litvinov, ...
Microscopy Research and Technique 85 (2), 562-569, 2022
202022
Experimental assessment of possible factors associated with tick-borne encephalitis vaccine failure
K Tuchynskaya, V Volok, V Illarionova, E Okhezin, A Polienko, O Belova, ...
Microorganisms 9 (6), 1172, 2021
142021
Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture
MF Vorovitch, KG Grishina, VP Volok, LL Chernokhaeva, KV Grishin, ...
Human vaccines & immunotherapeutics 16 (9), 2123-2130, 2020
142020
SARS-CoV-2 infection in children in Moscow in 2020: Clinical features and impact on circulation of other respiratory viruses: SARS-CoV-2 infection in children in Moscow in 2020
AS Yakovlev, IK Belyaletdinova, LN Mazankova, ER Samitova, ...
International Journal of Infectious Diseases 116, 331-338, 2022
102022
Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial
AA Ishmukhametov, AA Siniugina, NV Yagovkina, VI Kuzubov, ...
medRxiv, 2022.02. 08.22270658, 2022
82022
Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts
IV Gordeychuk, LI Kozlovskaya, AA Siniugina, NV Yagovkina, VI Kuzubov, ...
Viruses 15 (9), 1828, 2023
62023
Gut microbiome signature of Viliuisk encephalomyelitis in Yakuts includes an increase in microbes linked to lean body mass and eating behaviour
V Kuznetsova, A Tyakht, L Akhmadishina, V Odintsova, N Klimenko, ...
Orphanet journal of rare diseases 15, 1-11, 2020
52020
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID 19 (CoviVac) in preclinical studies. Emerg Microbes Infect. 2021; 10 (1 …
LI Kozlovskaya, AN Piniaeva, GM Ignatyev, IV Gordeychuk, VP Volok, ...
5
CoviVac vaccination induces production of neutralizing antibodies against Delta and Omicron variants of SARS-CoV-2
L Kozlovskaya, I Gordeychuk, A Piniaeva, A Kovpak, A Shishova, A Lunin, ...
MedRxiv, 2022.02. 10.22270781, 2022
42022
Cationic perylene antivirals with aqueous solubility for studies in vivo
AA Shtro, AV Garshinina, VA Alferova, PN Kamzeeva, VP Volok, ...
Pharmaceuticals 15 (10), 1178, 2022
32022
Progressive course of chronic tick-borne encephalitis manifesting as amyotrophic lateral sclerosis-like syndrome 35 years after the acute disease
VP Volok, LV Gmyl, IK Belyaletdinova, GG Karganova, EP Dekonenko
Brain Sciences 12 (8), 1020, 2022
32022
Effect of immature tick-borne encephalitis virus particles on antiviral activity of 5-aminoisoxazole-3-carboxylic acid adamantylmethyl esters
KK Tuchynskaya, AD Fomina, NA Nikitin, VV Illarionova, VP Volok, ...
Journal of General Virology 102 (9), 001658, 2021
32021
Development of a Promising Method for Producing Oligomeric Mixture of Branched Alkylene Guanidines to Improve Substance Quality and Evaluate Their Antiviral Activity against …
DO Shatalov, SA Kedik, IS Ivanov, AV Aydakova, DA Akhmedova, ...
Molecules 26 (11), 3472, 2021
32021
Возрастные особенности содержания эссенциальных и токсичных элементов в волосах часто болеющих детей
ЛН Исанкина, ЮН Лобанова, ВП Волок, ВИ Кулеш, АВ Скальный
Вопросы биологической, медицинской и фармацевтической химии 22 (8), 44-52, 2019
22019
Inactivated whole virion vaccine protects K18‐hACE2 Tg mice against the Omicron SARS‐CoV‐2 variant via cross‐reactive T cells and nonneutralizing antibody responses
AA Kruglov, MA Bondareva, VS Gogoleva, IK Semin, IV Astrakhantseva, ...
European Journal of Immunology 54 (3), 2350664, 2024
12024
Viral meningoencephalitis with damage to the right temporal lobe with a favorable outcome
TV Kirichenko, NV Turkot, MS Dodina, VP Volok, IK Belyaletdinova
Zhurnal Nevrologii i Psikhiatrii imeni SS Korsakova 122 (3), 112-116, 2022
12022
AGE DEPENDENCY OF ESSENTIAL AND TOXIC ELEMENT LEVELS IN HAIR OF FREQUENTLY ILL CHILDREN
LN Isankina, YN Lobanova, VP Volok, VI Kulesh, AV Skalny
Problems of Biological Medical and Pharmaceutical Chemistry 22 (8), 44-52, 2019
12019
系统目前无法执行此操作,请稍后再试。
文章 1–20